TEL
AVIV, Israel, Aug. 6, 2024
/PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE)
(TASE: ARBE) ("Arbe"), a global leader in Perception Radar
Solutions, today announced financial results for its second
quarter, ended June 30, 2024.
Key Q2 and Recent Company Highlights:
- Arbe's chipset was selected by one of the top ten OEMs
worldwide for the development of its next-generation imaging radar
aimed at serial production. The selection of Arbe's technology
presents a significant commercial opportunity given its
applicability across a wide range of vehicle classes.
- Arbe collaborates with a prominent European truck manufacturer
to revolutionize truck safety with Arbe's imaging radar. The
manufacturer is set to integrate Arbe's radar into its
next-generation sensor suite as part of the transition to an
advanced implementation stage.
- Arbe is actively engaged in achieving four design-ins with
leading global automakers. Despite longer decision cycles, Arbe
expects those decisions in the coming months.
- During the second quarter, Arbe participated in the final
stages of OEM RFQ processes along with its Tier 1s: Magna,
HiRain, Weifu, and Sensrad.
- The demand for high-channel count solutions is widespread
across the board, and Arbe's solution is
recognized by leading OEMs as the radar with the largest
channel array at the best price per channel.
- Arbe began trading on the Tel Aviv Stock Exchange (TASE) and
issued convertible debentures totaling approximately $30 million to Israeli investors. This strategic
move aims to bolster its cash reserves in anticipation of upcoming
OEM selections. The proceeds from the debenture offering are held
in escrow and will be released upon meeting certain conditions by
March 31, 2025.
"We are excited to announce that we have reached a significant
milestone with two key customers. The selection of our imaging
radar by both a leading OEM and a prominent European truck
manufacturer validates our technology and highlights its market
appeal. We are in the final stages of RFPs and RFQs with our Tier
1s, and we believe that we are on track to secure additional major
OEM selections this year," said Kobi
Marenko, Chief Executive Officer. "Arbe is well-positioned
to capitalize on the growing demand for advanced radar systems, and
we anticipate an increase in sales and market share in the near
future."
Second Quarter 2024 Financial Highlights
Revenues for Q2 2024 were $0.4 million, an increase from $0.3 million in Q2 2023. Backlog as of
June 30, 2024, was $0.8 million.
Negative gross margin for Q2 2024 was 9.5%, compared to negative
gross margin of 1% in Q2 2023, mainly related to headcount
increase.
Operating expenses in Q2 2024 were $11.6
million, compared to $12.6
million in Q2 2023. The decrease in operating expenses was
primarily driven by a decrease in R&D materials and to a lesser
extent due to a labor cost decrease, partially offset by doubtful
debts provision and debt issuance costs. Research and Development
decreased, from $9.1 million in Q2
2023 to $7.9 million in Q2 2024, the
decrease was mainly related to finalization and maturing stages of
production and labor cost savings. Sales and Marketing expenses
decreased from $1.5 million in Q2
2023 to $1.4 million in Q2 2024,
related to lower travel and conference expenses. General and
Administrative expenses increased from $2.0
million in Q2 2023 to $2.3
million in Q2 2024, later include a one-time provision and
offering fees.
As a result, our operating loss in Q2 2024 was $11.6 million compared to a $12.6 million loss in Q2 2023.
Net loss in the second quarter of 2024 decreased to $11.8 million, compared to a net loss of
$12.6 million in the second quarter
of 2023. Net loss in Q2 2024 included $0.1
million of financial expenses, consisting of foreign
exchange revaluations offset by interest from deposits.
Adjusted EBITDA, a non-GAAP measurement which excludes expenses
for non-cash share-based compensation and for non-recurring items,
for Q2 2024, yielded a loss of $7.5
million, compared to a loss of $8.4
million in the second quarter of 2023.
Balance Sheet and Liquidity
As of June 30, 2024, Arbe had
$8.8 million in cash and cash
equivalents and $17.7 million in
short term bank deposits. In June
2024, the Company issued convertible debentures in the
principal amount of NIS 110,000,000
(approximately $30 million). The
proceeds from the sale of the debentures, which were approximately
NIS 112,400,000 (approximately
$30.5 million), are held in escrow
and will be released to the Company upon meeting
certain conditions by March 31,
2025 (these funds are classified as other assets on our
balance sheet). The Company has incurred losses from operations
since its inception and has negative cash flow from operating
activities. Considering management's plans and the forecasted
revenue, we will have sufficient funds to finance our operation
needs in the foreseeable future.
Outlook
- Our goal of achieving 4 design-ins with automakers remains
unchanged, as we observe continued strong interest in our
market-leading offering.
- We have strengthened our position in all our RFQ
engagements, even though the OEMs have shifted their decision
timelines from late 2023 to 2024.
- The 2024 annual revenues are expected to be in line with those
of 2023, followed by revenue growth in 2025. These revenue
projections are based on our expectation that we will be in full
production in the second half of 2024, as well as our decision to
exclusively focus on getting our chipset into production.
- We are committed to maintaining a strong and well-managed
balance sheet, focusing on cost-effectiveness and the ability to
fund our revenue growth. Adjusted EBITDA for 2024 is projected to
be in the range of ($30) million to
($36) million.
Conference Call & Webcast Details
Arbe will host a conference call and webcast today at
8:30 am ET. Speakers will include
Kobi Marenko, Chief Executive
Officer, Co-Founder and Director, and Karine Pinto-Flomenboim,
Chief Financial Officer. The Company encourages participants to
pre-register for the conference call here. Callers will
receive a unique dial-in upon registration, which enables immediate
access to the call. Participants may pre-register at any time,
including up to and after the call start time.
The live call may be accessed via:
U.S. Toll Free: 1-844-481-3015
International:
1-412-317-1880
Israel Toll
Free: 1-809-212373
A telephonic replay of the conference call will be available
until August 20, 2024, following the
end of the conference call. To listen to the replay, please
dial:
U.S. Toll Free: 1-877-344-7529
International:
1-412-317-0088
Access ID: 6889354
A live webcast of the call can be accessed here or from
Arbe's Investor Relations website at
https://ir.arberobotics.com/news/ir-calendar. An archived webcast
of the conference call will also be made available on the website
following the call.
Arbe (Nasdaq: ARBE) (TASE: ARBE), a global leader in Perception
Radar Solutions, is spearheading a radar revolution, enabling truly
safe driver-assist systems today while paving the way to full
autonomous-driving. Arbe's radar technology is 100 times more
detailed than any other radar on the market and is a critical
sensor for L2+ and higher autonomy. The company is empowering
automakers, Tier-1 suppliers, autonomous ground vehicles,
commercial and industrial vehicles, and a wide array of safety
applications with advanced sensing and paradigm changing
perception. Arbe, a leader in the fast-growing automotive radar
market, is based in Tel Aviv,
Israel, and has offices in China, Germany, and the
United States.
Cautionary Note Regarding Forward-Looking Statements
This press release and the earnings call contains or will
contain "forward-looking statements" within the meaning of the
Securities Act of 1933 and the Securities Exchange Act of 1934,
both as amended by the Private Securities Litigation Reform Act of
1995. contains "forward-looking statements" within the meaning of
the Securities Act of 1933 and the Securities Exchange Act of 1934,
both as amended by the Private Securities Litigation Reform Act of
1995. The words "expect," "believe," "estimate," "intend," "plan,"
"anticipate," "may," "should," "strategy," "future," "will,"
"project," "potential" and similar expressions indicate
forward-looking statements. Forward-looking statements are
predictions, projections and other statements about future events
that are based on current expectations and assumptions and, as a
result, are subject to risks and uncertainties. These risks and
uncertainties include, the effect on the Israeli economy generally
and on the Company's business resulting from the terrorism and the
hostilities in Israel and with its
neighboring countries including the effects of the continuing war
with Hamas and any further intensification of hostilities with
others, including Iran and
Hezbollah, and the effect of the call-up of a significant portion
of its working population, including the Company's employees; the
effect of any potential boycott both of Israeli products and
business and of stocks in Israeli companies; the effect of any
downgrading of the Israeli economy and the effect of changes in the
exchange rate between the US dollar and the Israeli shekel; the
Company's ability to meet the conditions to the release from escrow
of the proceeds from its recent sale of convertible debentures; the
Company's ability to generate additional OEM selections and
substantial orders and the risk and uncertainties described in
"Cautionary Note Regarding Forward-Looking Statements," "Item 3.
Key Information – D. Risk Factors" and "Item 5. Operating and
Financial Review and Prospects" and in the Company's Annual Report
on Form 20-F for the year ended December 31,
2023, which was filed with the Securities and Exchange
Commission (the "SEC") on March 28,
2024, as well as other documents filed by the Company with
the SEC. Accordingly, you are cautioned not to place undue reliance
on these forward-looking statements. Forward-looking statements
relate only to the date they were made, and the Company does not
undertake any obligation to update forward-looking statements to
reflect events or circumstances after the date they were made
except as required by law or applicable regulation.
Information contained on, or that can be accessed through, the
Company's website or any other website or any social media is
expressly not incorporated by reference into and is not a part of
this press release.
Logo:
https://mma.prnewswire.com/media/803813/Arbe_Robotics_Logo.jpg
CONSOLIDATED BALANCE
SHEETS
|
(U.S. dollars in
thousands)
|
|
|
|
|
|
|
June 30,
2024
|
|
December 31,
2023
|
Current
Assets:
|
|
(Unaudited)
|
|
(Unaudited)
|
Cash and cash
equivalents
|
|
8,840
|
|
28,587
|
Restricted
cash
|
|
280
|
|
163
|
Short term bank
deposits
|
|
17,683
|
|
15,402
|
Trade
receivable
|
|
694
|
|
1,258
|
Other assets
|
|
30,545
|
|
-
|
Prepaid expenses and
other receivables
|
|
1,954
|
|
2,026
|
Total current
assets
|
|
59,996
|
|
47,436
|
|
|
|
|
|
Non-Current
Assets
|
|
|
|
|
Operating lease
right-of-use assets
|
|
1,895
|
|
1,740
|
Property and equipment,
net
|
|
1,434
|
|
1,309
|
Total non-current
assets
|
|
3,329
|
|
3,049
|
|
|
|
|
|
Total
assets
|
|
63,325
|
|
50,485
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
Trade
payables
|
|
832
|
|
1,149
|
Operating lease
liabilities
|
|
519
|
|
436
|
Employees and payroll
accruals
|
|
3,265
|
|
2,916
|
Convertible
debentures
|
|
29,982
|
|
-
|
Accrued expenses and
other payables
|
|
1,097
|
|
1,710
|
Total current
liabilities
|
|
35,695
|
|
6,211
|
|
|
|
|
|
Long term
liabilities
|
|
|
|
|
Operating lease
liabilities
|
|
1,512
|
|
1,306
|
Warrant
liabilities
|
|
607
|
|
875
|
Total long-term
liabilities
|
|
2,119
|
|
2,181
|
|
|
|
|
|
SHAREHOLDERS'
EQUITY:
|
|
|
|
|
Ordinary
Shares
|
|
*)
|
|
*)
|
Additional paid-in
capital
|
|
253,702
|
|
245,733
|
Accumulated
Deficit
|
|
(228,191)
|
|
(203,640)
|
Total shareholders'
equity
|
|
25,511
|
|
42,093
|
|
|
|
|
|
Total liabilities
and shareholders' equity
|
|
63,325
|
|
50,485
|
|
|
|
|
|
*) Represents less than
$1.
|
|
|
|
|
CONSOLIDATED
STATEMENTS OF OPERATIONS
|
|
(U.S. dollars in
thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
6 Months
Ended
|
|
6 Months
Ended
|
|
|
|
June 30,
2024
|
|
June 30,
2023
|
|
June 30,
2024
|
|
June 30,
2023
|
|
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
Revenues
|
|
409
|
|
289
|
|
546
|
|
644
|
|
Cost of
revenues
|
|
448
|
|
292
|
|
851
|
|
608
|
|
Gross profit
(loss)
|
|
(39)
|
|
(3)
|
|
(305)
|
|
36
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Expenses:
|
|
|
|
|
|
|
|
|
|
Research and
development, net
|
7,914
|
|
9,091
|
|
17,311
|
|
17,215
|
|
Sales and
marketing
|
|
1,365
|
|
1,478
|
|
2,818
|
|
2,402
|
|
General and
administrative
|
|
2,296
|
|
2,014
|
|
3,940
|
|
3,644
|
|
Total operating
expenses
|
|
11,575
|
|
12,583
|
|
24,069
|
|
23,261
|
|
|
|
|
|
|
|
|
|
|
|
Operating
loss
|
|
(11,614)
|
|
(12,586)
|
|
(24,374)
|
|
(23,225)
|
|
|
|
|
|
|
|
|
|
|
|
Financial expenses
(income), net
|
|
132
|
|
25
|
|
177
|
|
(707)
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
(11,746)
|
|
(12,611)
|
|
(24,551)
|
|
-22,518
|
|
|
|
|
|
|
|
|
|
|
|
Basic net loss per
ordinary share
|
|
(0.15)
|
|
(0.19)
|
|
(0.31)
|
|
(0.34)
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of
shares used in computing basic
net loss per ordinary share
|
|
80,578,820
|
|
67,762,711
|
|
79,377,515
|
|
66,225,739
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net loss per
ordinary share
|
|
(0.19)
|
|
(0.23)
|
|
(0.39)
|
|
(0.39)
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of
shares used in computing
diluted net loss per ordinary share
|
|
64,204,137
|
|
56,450,209
|
|
63,390,411
|
|
58,419,059
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
|
(U.S. dollars in
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
6 Months
Ended
|
|
6 Months
Ended
|
|
|
|
June 30,
2024
|
|
June 30,
2023
|
|
June 30,
2024
|
|
June 30,
2023
|
|
Cash flows from
operating activities:
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
Net
Loss
|
|
(11,746)
|
|
(12,611)
|
|
(24,551)
|
|
(22,518)
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to
reconcile loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
|
Depreciation
|
|
147
|
|
139
|
|
289
|
|
276
|
|
Stock-based
compensation
|
|
3,587
|
|
3,713
|
|
7,313
|
|
5,721
|
|
Warrants to service
providers
|
|
286
|
|
157
|
|
634
|
|
254
|
|
Revaluation of warrants
and accretion
|
|
(157)
|
|
(369)
|
|
(268)
|
|
(238)
|
|
Convertible debentures
accretion
|
|
176
|
|
-
|
|
176
|
|
-
|
|
Change in operating
assets and liabilities:
|
|
|
|
|
|
|
|
|
|
Decrease in trade
receivable
|
|
162
|
|
48
|
|
564
|
|
162
|
|
Decrease in prepaid
expenses and other receivables
|
|
245
|
|
330
|
|
72
|
|
504
|
|
Increase in other
assets
|
|
(128)
|
|
-
|
|
(128)
|
|
-
|
|
Operating lease ROU
assets and liabilities, net
|
|
6
|
|
(8)
|
|
135
|
|
-
|
|
Decrease in trade
payables
|
|
(1,039)
|
|
(1,116)
|
|
(506)
|
|
(284)
|
|
Increase (decrease) in
employees and payroll accruals
|
|
204
|
|
43
|
|
349
|
|
(550)
|
|
Decrease in accrued
expenses and other payables
|
|
(72)
|
|
(499)
|
|
(766)
|
|
(3,706)
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in
operating activities
|
|
(8,328)
|
|
(10,173)
|
|
(16,687)
|
|
(20,379)
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
investing activities:
|
|
|
|
|
|
|
|
|
|
Change in bank
deposits
|
|
12,621
|
|
(25,602)
|
|
(2,281)
|
|
(25,202)
|
|
Purchase of property
and equipment
|
|
(126)
|
|
(87)
|
|
(225)
|
|
(119)
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by
(used in) investing activities
|
|
12,494
|
|
(25,689)
|
|
(2,506)
|
|
(25,321)
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance
of ordinary shares, net of issuance costs
|
|
-
|
|
22,496
|
|
-
|
|
22,496
|
|
Issuance costs related
to convertible debentures
|
|
(459)
|
|
-
|
|
(459)
|
|
-
|
|
Proceeds from exercise
of options
|
|
22
|
|
46
|
|
22
|
|
606
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by
(used in)
financing activities
|
|
(437)
|
|
22,542
|
|
(437)
|
|
23,102
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate
fluctuations on cash and cash equivalent
|
|
80
|
|
(574)
|
|
214
|
|
(66)
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in
cash, cash equivalents and restricted cash
|
|
3,650
|
|
(12,746)
|
|
(19,844)
|
|
(22,532)
|
|
Cash, cash equivalents
and restricted cash at the beginning of period
|
|
5,391
|
|
45,037
|
|
28,750
|
|
54,315
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash
equivalents and restricted cash at the end of period
|
|
9,120
|
|
31,717
|
|
9,120
|
|
31,717
|
|
RECONCILIATION OF
GAAP NET LOSS TO NON-GAAP NET LOSS
|
|
(U.S. dollars in
thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
6 Months
Ended
|
|
6 Months
Ended
|
|
|
|
June 30,
2024
|
|
June 30,
2023
|
|
June 30,
2024
|
|
June 30,
2023
|
|
GAAP net loss
attributable to ordinary shareholders
|
|
(11,746)
|
|
(12,611)
|
|
(24,551)
|
|
(22,518)
|
|
|
|
|
|
|
|
|
|
|
|
Add:
|
|
|
|
|
|
|
|
|
|
Stock-based
compensation
|
|
3,587
|
|
3,713
|
|
7,313
|
|
5,721
|
|
Warrants to service
providers
|
|
286
|
|
157
|
|
634
|
|
254
|
|
Revaluation of warrants
and accretion
|
|
(157)
|
|
(369)
|
|
(268)
|
|
(238)
|
|
Convertible debentures
accretion
|
|
176
|
|
-
|
|
176
|
|
-
|
|
Non-recurring expenses
related to convertible debentures and ATM
|
805
|
|
214
|
|
805
|
|
214
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net
loss
|
|
(7,048)
|
|
(8,896)
|
|
(15,890)
|
|
(16,567)
|
|
|
|
|
|
|
|
|
|
|
|
Basic Non-GAAP net loss
per ordinary share
|
|
(0.09)
|
|
(0.13)
|
|
(0.20)
|
|
(0.25)
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of shares used in computing basic
Non-GAAP net loss per ordinary share
|
|
80,578,820
|
|
67,762,711
|
|
79,377,515
|
|
66,225,739
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Non-GAAP net
loss per ordinary share
|
|
(0.09)
|
|
(0.16)
|
|
(0.14)
|
|
(0.29)
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of shares used in computing diluted
Non-GAAP net loss per ordinary share
|
|
64,204,137
|
|
56,450,209
|
|
63,390,411
|
|
58,419,059
|
|
|
|
|
|
|
|
|
|
|
|
RECONCILIATION OF
GAAP NET LOSS TO ADJUSTED EBITDA
|
|
(U.S. dollars in
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
6 Months
Ended
|
|
6 Months
Ended
|
|
|
|
June 30,
2024
|
|
June 30,
2023
|
|
June 30,
2024
|
|
June 30,
2023
|
|
GAAP net loss
attributable to ordinary shareholders
|
|
(11,746)
|
|
(12,611)
|
|
(24,551)
|
|
(22,518)
|
|
|
|
|
|
|
|
|
|
|
|
Add:
|
|
|
|
|
|
|
|
|
|
Financial expenses
(income), net
|
|
132
|
|
25
|
|
177
|
|
(707)
|
|
Depreciation
|
|
147
|
|
139
|
|
289
|
|
276
|
|
Stock-based
compensation
|
|
3,587
|
|
3,713
|
|
7,313
|
|
5,721
|
|
Warrants to service
providers
|
|
286
|
|
157
|
|
634
|
|
254
|
|
Non-recurring expenses
related to ATM
|
|
68
|
|
214
|
|
68
|
|
214
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA
|
|
(7,526)
|
|
(8,363)
|
|
(16,070)
|
|
(16,760)
|
|
|
|
|
|
|
|
|
|
|
|
View original
content:https://www.prnewswire.com/news-releases/arbe-announces-q2-2024-financial-results-302215349.html
SOURCE Arbe